Skip to content

Assessment of applicability and results of nerve electrical stimulation in the treatment of children with intractable intestinal constipation

Evaluation of applicability and clinical outcomes transcutaneous electrical nerve stimulation posterior treatment of children with constipation intractable intestinal

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-344jq8
Enrollment
Unknown
Registered
2018-03-13
Start date
2018-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation

Interventions

We propose a clinical, longitudinal, cohort, prospective, uncontrolled clinical study whose data collection will occur in the 12-month period. The sample will be composed of 30 children, aged between
Modified Bristol scale for children (mBSFS-C) for analysis of stool consistency
Intestine Function Index (BF-S)
Fecal continence index
PEDs 4.0 questionnaire for quality of life assessment
Questionnaire to evaluate the applicability of the sessions
the last 7 days.
Device
E02.331.800
C23.888.821.150

Sponsors

Universidade Estadual Paulista “Júlio de Mesquita Filho” Faculdade de Medicina de Botucatu-FMB/UNESP
Lead Sponsor
Universidade Estadual Paulista “Júlio de Mesquita Filho” Faculdade de Medicina de Botucatu-FMB/UNESP
Collaborator

Eligibility

Age
7 Years to 18 Years

Inclusion criteria

Inclusion criteria: Patients between the ages of 7 and 18 years of age, of both sexes, with a diagnosis of CIC, established according to the criteria of Rome IV, and classified as having intractable intestinal constipation, according to the definition of the European Societies ( ESPGHAN) and North American (NASPGHAN) Gastropediatrics, represented by patients unresponsive to standard treatment, after a period of threE months

Exclusion criteria

Exclusion criteria: Patients whose parents and / or guardians do not agree to participate in the study and who do not sign the Free and Informed Consent Term, as well as patients between the ages of 12 and 18 who do not sign their consent form, will be excluded. Patients with any identifiable organic cause for intestinal constipation will be excluded from the study. Exclusion criteria will also be considered: neurological and / or cognitive deficits, skin lesions in the region of application of electrodes, changes in local sensitivity, presence of cardiac pacemaker, children presenting with cardiac arrhythmias or cardiac arrhythmias, patients presenting incomplete questionnaires or that are subject to drug changes and the standard during the intervention period or who abandon the proposed electrostimulation treatment during the intervention period

Design outcomes

Primary

MeasureTime frame
Improvement in the evacuation pattern and in the quality of life of the children submitted to the intervention. The following instruments will be used to evaluate and quantify this expected improvement: Asked about the evaluation of the current clinical state; Modified Bristol scale for children (mBSFS-C) for stool consistency analysis; Intestine Function Index (BF-S); Fecal continence index; PEDs 4.0 questionnaire for quality of life assessment; the last 7 days.;The possibility of applying the electrostimulation therapy in a home environment, identified through a directed questionnaire to evaluate the applicability of the sessions.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactRebeca Rego

Universidade Estadual Paulista “Júlio de Mesquita Filho” Faculdade de Medicina de Botucatu-FMB/UNESP

rebecamayarafisio@gmail.com+55 (14) 3880 1703

Outcome results

None listed

Source: REBEC (via WHO ICTRP)